|
Volumn 46, Issue 1, 2008, Pages 51-54
|
Effect of the raloxifene versus combined hormonal therapy on the mammary density;Efecto del raloxifeno versus terapia hormonal combinada sobre la densidad mamaria.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BONE DENSITY CONSERVATION AGENT;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
AGED;
ARTICLE;
BONE DENSITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
FEMALE;
HISTOLOGY;
HUMAN;
MAMMARY GLAND;
METABOLIC BONE DISEASE;
MIDDLE AGED;
PATHOLOGY;
POSTMENOPAUSE OSTEOPOROSIS;
RISK;
AGED;
BONE DENSITY;
BONE DENSITY CONSERVATION AGENTS;
BONE DISEASES, METABOLIC;
FEMALE;
HUMANS;
MAMMARY GLANDS, HUMAN;
MIDDLE AGED;
ODDS RATIO;
OSTEOPOROSIS, POSTMENOPAUSAL;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
|
EID: 48449089633
PISSN: 04435117
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|